Loading…
Loading…
IDXX · NASDAQ · Healthcare
“Despite IDXX's dominant veterinary diagnostics franchise, the 43.5x earnings multiple leaves precious little margin of safety for even the most optimistic intrinsic value calculations.”
— In the voice of Graham
Track upcoming IPOs for the next three months. Filter by sector and expected valuation range.
Market Cap
$46.08B
P/E Ratio
43.50
Forward P/E
—
EPS
$13.17
PEG Ratio
2.51
Book Value
$19.96
Dividend Yield
—
Profit Margin
24.62%
ROE
65.99%
Use the interactive ipo calendar with pre-loaded data for Idexx Laboratories Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for IDXX: